Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus

Gene

Volumn 62, Issue 1, 1988, Pages 75-84

  Angel Martinez, Miguel ^a   Carrillo, Consuelo ^a   Plana, Joan ^b   Mascardla, Ricard ^b   Bergada, Josep ^b   Palma, Eduarde L ^c   Domingo, Esteban ^c   Sobrino, Francisco ^a  

^a INIA   (Spain)

^b Laboratories Sobrino SA Vall de Bianya Girona Spain Tel 72 290001 ^*

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

molecular epidemiology; Nucleotide sequencing of RNA; protection against FMD; vaccine; VP1 comparison

Indexed keywords

RADIOISOTOPE; VACCINE; VIRUS PROTEIN;

FOOT AND MOUTH DISEASE VIRUS; GENETIC ENGINEERING; HEREDITY; NONHUMAN; NORMAL VALUE; NUCLEOTIDE SEQUENCE; RNA STRUCTURE; SEROTYPE;

ANIMAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; APHTHOVIRUS; BASE SEQUENCE; CAPSID; EPITOPES; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; SWINE; VARIATION (GENETICS); VIRAL VACCINES;

EID: 0023906350     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1119(88)90581-1     Document Type: Article

References (37)

1. Foot-and-mouth disease virus
2. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus
3. T: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavage
4. The proportion of revenant and mutant phage in a growing population as a function of mutation and growth rate
5. The molecular basis of the antigenic variation of foot-and-mouth disease virus
6. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination
7. Protection against foot-and-mouth disease by immunization with a chemically-synthesized peptide predicted from the viral nucleotide sequence
8. FMD, a world
9. Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus
10. A model of evolutionary change in protein
11. Resolution of a common RNA sequencing ambiguity by terminal deoxynucleotidyl transferase
12. Protection of cattle against foot-and-mouth disease by a synthetic peptide
13. In vitro site-directed mutagenesis: generation and properties of an infectious extracistronic mutant of bacteriophage Qβ
14. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth disease virus
15. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance — a review
16. High error rates, population equilibrium and evolution of RNA replication systems
17. Self-organization of matter and the evolution of biological macromolecules
18. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein
19. Rapid evolution of RNA genomes
20. Neutralisation en culture cellulaire du pouvoir infectieux du virus de la fièvre aphteuse par des serums provenant de porcs immunisès a l'aide d'une protèine virale purifièe
21. Comparison of the amino acid sequence of the major immunogen from three serotypes of foot and mouth disease virus
22. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease virus
23. An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type O induces neutralizing activity but poor protection
24. Evidence that the hypervariable region 41–60 of FMDV VP1 has a distal effect on the major immunogenic site
25. Measurement of the mutation rate of animal viruses: influenza A virus and poliovirus type 1
26. Foot-and-mouth disease
27. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus
28. A simple method to estimate fifty percent end points
29. Chemical basis of antigenic variation in foot-and-mouth disease virus
30. Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction
31. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture
32. Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations
33. Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA
34. Location and characterization of the antigenic portion of the FMDV immunizing protein
35. 1-Santa Pau (C-S8). Sequence of protein VP1 coding segment
36. 3'-Terminalnucleotide sequence of encephalomyocarditis virus RNA determined by reverse transcriptase and chain-terminating inhibitors